Expert Outlook: Gilead Sciences Through The Eyes Of 8 Analysts
Expert Outlook: Gilead Sciences Through The Eyes Of 8 Analysts
专家展望：吉利德科学在8位分析师眼中的表现
Investigating Analyst Ratings: An Elaborate...Across the recent three months, 8 analysts have shared their insights on Gilead Sciences (NASDAQ:GILD), expressing a variety of opinions spanning from bullish to bearish.
在最近三个月，8名分析师分享了他们对吉利德科学（纳斯达克：GILD）的见解，表达了从看好到看淡的不同观点。
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
在下表中，您将找到他们最近的评级摘要，揭示了过去30天内情绪的变化，并将它们与前几个月进行比较。
In the assessment of 12-month price targets, analysts unveil insights for Gilead Sciences, presenting an average target of $77.25, a high estimate of $93.00, and a low estimate of $70.00. Observing a 3.19% increase, the current average has risen from the previous average price target of $74.86.
在评估为期12个月的价格目标时，分析师揭示了有关吉利德科学的见解，提供了$77.25的平均目标，$93.00的高估值和$70.00的低估值。观察到3.19%的增长，当前平均值已经从先前的平均价格目标$74.86上升。
Investigating Analyst Ratings: An Elaborate...
分析师评级...
登录免费看全文
登录/注册
资讯热榜
更新时间